Plan dose evaluation of three dimensional conformal radiotherapy planning (3D-CRT) of nasopharyngeal carcinoma (NPC): Experience of a tertiary care university hospital in Pakistan

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 10, 2013, Pages 5989-5993

  Abbasi, Ahmed Nadeem ^a   Hafiz, Asim ^a   Ali, Nasir ^a   Khan, Khurshid Ahmed ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

Nasopharyngeal carcinoma; Plan dose evaluation; Three dimensional conformal radiotherapy (3D CRT)

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CHILD; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; NASOPHARYNX TUMOR; PAKISTAN; PATHOLOGY; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; THREE DIMENSIONAL IMAGING; UNIVERSITY HOSPITAL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, UNIVERSITY; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PAKISTAN; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; TERTIARY HEALTHCARE; YOUNG ADULT;

EID: 84890495979     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.10.5989     Document Type: Article

References (23)

1. Abbasi AN, Zahid S, Bhurgri Y, et al (2011). Nasopharyngeal carcinoma-an update of treatment and acute radiation induced reactions from a tertiary-care hospital in Pakistan. Asian Pac J Cancer Prev, 12, 735-8.
2. Baujat B, Audry H, Bourhis J, et al (2006). Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys, 64, 47-56.
3. Bhide SA, Newbold KL, Harrington KJ, et al (2012). Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers. Br J Radiol, 85, 487-94.
4. Chau RM, Teo PM, Choi PH, et al (2001). Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma. Radiother Oncol, 58, 143-53.
5. Chen J, Huang WX, Wei W, et al (2012). Surgical management for residual or recurrent diseases in the neck after radiotherapy in nasopharyngeal carcinoma. Chinese J Otorhinolaryngology Head and Neck Surgery, 47,180-4.
6. Chung JB, Lee JW, Kim JS, et al (2011). Comparison of target coverage and dose to organs at risk between simultaneous integrated-boost whole-field intensity-modulated radiation therapy and junctioned intensity-modulated radiation therapy with a conventional radiotherapy field in treatment of nasopharyngeal carcinoma. Radiol Phys Technol, 4, 180-4.
7. Guo R, Sun Y, Yu XL, et al (2012). Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma? Radiother Oncol, 104, 294-9.
8. Hsiung CY, Yorke ED, Chui CS, et al (2002). Intensitymodulated radiotherapy versus conventional threedimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 53, 638-47.
9. Hunt MA, Zelefsky MJ, Wolden S, et al (2001). Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol Phys, 49, 623-32.
10. Jemal A, Center MM, DeSantis C, et al (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 19, 1893-907.
11. Kam MK, Chau RM, Suen J, et al (2003). Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys, 56,145-57.
12. Lee N, Xia P, Quivey JM, et al (2002). Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys, 53, 12-22.
13. Liu MT, Hsieh CY, Chang TH, et al (2003). Prognostic factors affecting the outcome of nasopharyngeal carcinoma. Jpn J Clin Oncol, 33, 501-8.
14. Nishioka T, Shiga T, Shirato H, et al (2002). Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys, 53, 1051-7.
15. Ogawa K, Yoshioka Y, Isohashi F, et al (2013). Radiotherapy targeting cancer stem cells: current views and future perspectives. Anticancer Res, 33, 747-54.
16. Rasch CR, Steenbakkers RJ, Fitton I, et al (2010). Decreased 3D observer variation with matched CT-MRI, for target delineation in Nasopharynx cancer. Radiat Oncol, 5, 21.
17. Sarisahin M, Cila A, Ozyar E, et al (2010). Prognostic significance of tumor volume in nasopharyngeal carcinoma. Auris Nasus Larynx, 38, 250-4.
18. Sharma TD, Singh TT, Laishram RS, et al (2011). Nasopharyngeal carcinoma--a clinico-pathological study in a regional cancer centre of northeastern India. Asian Pac J Cancer Prev, 12, 1583-7.
19. Teo PM, Leung SF, Tung SY, et al (2006). Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG). Radiother Oncol, 79, 27-33.
20. Teo PM, Ma BB, Chan AT (2004). Radiotherapy for nasopharyngeal carcinoma--transition from two-dimensional to three-dimensional methods. Radiother Oncol, 73, 163-72.
21. Tribius S, Bergelt C (2011). Intensity-modulated radiotherapy versus conventional and 3D conformal radiotherapy in patients with head and neck cancer: is there a worthwhile quality of life gain? Cancer Treat Rev, 37, 511-9.
22. Waldron J, Tin MM, Keller A, et al (2003). Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma. Radiother Oncol, 68, 153-61.
23. Zhou JY, Chong VF, Khoo JB, et al (2007). The relationship between nasopharyngeal carcinoma tumor volume and TNM T-classification: a quantitative analysis. Eur Arch Otorhinolaryngol, 264, 169-74.